Since 1988, the family-owned company has focused on innovative drugs in Pediatrics and Infectiology.

Today, InfectoPharm manages a highly diversified portfolio with more than 130 products and 30 strategic partnerships globally.

In 2017, the London Stock Exchange Group (LSEG) identified InfectoPharm among the 1000 fastest growing European SMEs worth of attention.

In 2020, InfectoPharm reached an annual turnover of about 200 million euros.

In 2024 InfectoPharm establishes the subsidiary in UK.

Knowledge is Health – we are committed to lifelong learning and ongoing exchange with practitioners and partners as well as medical experts in science and research all over the world.

Partnering with InfectoPharm ensures you access to outstanding products and proven marketing concepts, combined with solid scientific support and 35 years of experience in collaborating with pediatricians.

Our product portfolio for international distribution includes medicinal products, medical devices and cosmetics. We are always keen to break new grounds – discover our innovations for infectiology and pediatrics.